These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26645886)

  • 1. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin B receptor promotes the proliferation and immune escape of malignant gliomas.
    Pan DS; Feng SZ; Cao P; Li JJ
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1230-1235. PubMed ID: 28841806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of immune phenotype with IDH mutation in diffuse glioma.
    Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
    Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
    Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
    Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and Quantitative Analysis of IDH1 Mutation in Progressive Gliomas by Allele-Specific qPCR and Western Blot Analysis.
    Perrech M; Dreher L; Röhn G; Stavrinou P; Krischek B; Toliat M; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828396. PubMed ID: 30943868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
    Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
    Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.
    Odia Y; Orr BA; Bell WR; Eberhart CG; Rodriguez FJ
    J Neurooncol; 2013 Nov; 115(2):249-59. PubMed ID: 23934175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
    Vasaikar S; Tsipras G; Landázuri N; Costa H; Wilhelmi V; Scicluna P; Cui HL; Mohammad AA; Davoudi B; Shang M; Ananthaseshan S; Strååt K; Stragliotto G; Rahbar A; Wong KT; Tegner J; Yaiw KC; Söderberg-Naucler C
    BMC Cancer; 2018 Feb; 18(1):154. PubMed ID: 29409474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of p42.3 in low- and high-grade gliomas.
    Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
    World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of cry1 and cry2 in human gliomas.
    Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
    Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
    Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
    Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas.
    Zhang L; He L; Lugano R; Roodakker K; Bergqvist M; Smits A; Dimberg A
    Neuro Oncol; 2018 Oct; 20(11):1505-1516. PubMed ID: 29846705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo Metabolic Profiles as Determined by
    Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
    Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
    Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
    J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
    Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
    Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.